Obituary
Journal Title: Iranian Journal of Blood and Cancer - Year 2013, Vol 5, Issue 3
Abstract
This article has no abstract.
Authors and Affiliations
Mardawig Alebouyeh
Keywords
Related Articles
- EP ID EP365843
- DOI -
- Views 61
- Downloads 0
Hydroxyurea Can Reduce or Eliminate Transfusion Requirements in Children with Major and Intermediate Thalassemia
Background: Hydroxyurea (HU) is a well known chemotherapeutic agent that has been used largely for various myeloproliferative diseases over the past 20 years. In β-thalassemia, the effect of HU is much less clear and rem...
Haemovigilance in Iran (First Report)
Haemovigilance is a system with standard program to cover the entire transfusion chain, monitor, evaluate and analyse the data to improve patients’ safety. We report the implemented haemovigilance system in hospitals an...
The Prognostic Value of White Blood Cells Count in Patients with Myocardial Infarction
Background: Ischemic heart disease and acute myocardial infarction is one of the most dramatic manifestations in one of the most investigated fields in the past few decades. In this study, the prognostic value of white b...
ABO blood groups and prognosis of breast cancer: a case-control study in Arak/Iran
Background: To explore a possible rela!onship among blood groups and the prognosis of breast cancer, this case- control study was carried out in Arak city, Arak province, Iran. Materials and Methods: One hundred and thir...
Short-term Chelating Efficacy of Deferoxamine in Iron Overloaded Rat Hepatocytes
Abstract Background: Iron overload is a clinical consequence of repeated blood transfusions and causes significant organ damage, morbidity, and mortality in the absence of proper treatment. The primary targets of Iron ch...